Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
SAVA | US
-0.35
-2.88%
Healthcare
Biotechnology
31/03/2024
02/07/2024
11.79
11.94
12.66
11.35
Cassava Sciences Inc. a clinical stage biotechnology company develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam a small molecule drug which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics Inc. and changed its name to Cassava Sciences Inc. in March 2019. The company was incorporated in 1998 and is based in Austin Texas.
View LessNegative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
Low negative Beta, possible Low Liquidity (< -0.4)
High Short percentage (> 15%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
172.8%1 month
122.4%3 months
97.6%6 months
79.4%-
34.01
7.16
-
-
-8.26
-
-
-97.93M
565.64M
565.64M
-
-
-
-
-33.90
18.97
28.13
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
11.71
Range1M
13.66
Range3M
17.89
Rel. volume
1.36
Price X volume
33.39M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
GH Research PLC Ordinary Shares | GHRS | Biotechnology | 11.91 | 619.65M | 1.36% | n/a | 0.43% |
Travere Therapeutics Inc. | TVTX | Biotechnology | 8.09 | 615.88M | -2.29% | n/a | 545.44% |
Scholar Rock Holding Corporation | SRRK | Biotechnology | 7.63 | 608.52M | -6.15% | n/a | 32.90% |
Humacyte Inc | HUMA | Biotechnology | 5.11 | 608.52M | -4.84% | n/a | 71.00% |
PHATHOM PHARMACEUTICALS INC. | PHAT | Biotechnology | 10.25 | 599.99M | -5.18% | n/a | -315.85% |
Savara Inc | SVRA | Biotechnology | 4.3 | 594.21M | -7.33% | n/a | 21.80% |
Arbutus Biopharma Corporation | ABUS | Biotechnology | 3.13 | 590.68M | 0.32% | n/a | 7.05% |
OLMA | OLMA | Biotechnology | 10.41 | 582.27M | -6.55% | n/a | 0.93% |
Mineralys Therapeutics Inc. | MLYS | Biotechnology | 12.09 | 581.27M | -0.66% | n/a | 0.00% |
PureTech Health plc | PRTC | Biotechnology | 24.2 | 579.15M | -0.21% | n/a | 5.50% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Ennis Inc | EBF | Building Products & Equipment | 21.9 | 569.05M | 0.23% | 13.68 | 1.15% |
ACCO Brands Corporation | ACCO | Building Products & Equipment | 4.63 | 442.81M | 0.87% | n/a | 138.85% |
ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 26.72 | 428.14M | 1.52% | n/a | 322.60% |
Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 11.98 | 376.70M | 2.04% | 14.12 | 86.68% |
Latham Group Inc. | SWIM | Building Products & Equipment | 2.9 | 335.16M | 0.35% | 75.75 | 80.81% |
Marine Products Corporation | MPX | Recreational Vehicles | 9.5 | 329.49M | 0.53% | 10.10 | 0.00% |
CPI Card Group Inc | PMTS | Building Products & Equipment | 27.45 | 305.31M | 1.10% | 17.47 | -562.47% |
MCBC Holdings Inc | MCFT | Recreational Vehicles | 17.76 | 301.58M | -1.11% | 8.24 | 25.57% |
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 13.54 | 219.45M | 1.58% | 8.94 | 15.44% |
Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 45.51 | 130.85M | 3.43% | 7.40 | 89.91% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -8.26 | -2.43 | Cheaper |
Ent. to Revenue | - | 4,101.76 | - |
PE Ratio | - | 41.26 | - |
Price to Book | 7.16 | 22.34 | Cheaper |
Dividend Yield | - | 2.39 | - |
Std. Deviation (3M) | 97.56 | 76.52 | Riskier |
Debt to Equity | - | 0.51 | - |
Debt to Assets | - | 0.24 | - |
Market Cap | 565.64M | 3.77B | Emerging |